India, Feb. 10 -- Merck KGaA (MKGAY.PK) announced that it is in advanced talks with SpringWorks Therapeutics, Inc. (SWTX) about a possible acquisition. However, Merck clarified that no legally binding agreement has been made yet. There is no guarantee that a deal will be reached, and several key conditions still need to be fulfilled.
SWTX closed Monday regular trading at $54.00 up $13.72 or 34.06%. In the after-hours trading, the stock further gained $0.48 or 0.88%.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....